Table 2 New-onset CVD events during a median 24 months follow-up in patients undergoing haemodialysis stratified according to Non-HDL-C quartile
Event | Patient groups based on Non-HDL-C levels | ||||
|---|---|---|---|---|---|
Q1 < 2.24 | 2.24 ≤ Q2<2.76 | 2.76 ≤ Q3<3.45 | Q4 ≥ 3.45 | ||
n = 314 | n = 323 | n = 326 | n = 325 | p-value | |
Total CVD events | 6(4.3%) | 9(6.4%) | 23(16.3%) | 103(73.0%) | 0.029 |
Myocardial infarction | 0(0.0%) | 1(0.7%) | 6(4.3%) | 32(22.7%) | |
Cerebral infarction | 3(2.1%) | 5(3.5%) | 8(5.7%) | 16(11.3%) | |
Cerebral haemorrhage | 1(0.7%) | 2(1.4%) | 7(5.0%) | 45(31.9%) | |
Acute coronary syndrome | 2(1.4%) | 1(0.7%) | 2(1.4%) | 10(7.1%) | |